| dbo:abstract
|
- MBDB neboli N-metyl-1-(1,3-benzodioxol-5-yl)-2-butanamin je fenylethylamin chemický blízký MDMA (extázi). Je nazýván také "EDEN" nebo "Methyl-J". Používá se experimentálně v psychoterapii také jako droga. Poprvé byl syntetizován , později ho pro jeho psychoaktivní účinky zkoumal . Ten o něm napsal knihu PiHKAL (Phenyletylamines I Have Known And Loved - Fenyletylaminy které znám a miluji). V Evropě se vyskytuje ve formě tablet vydávaných za extázi, jedná se asi o 1 % případů. Někdy bývá s kombinaci s jinými látkami (MDMA, LSD, ketamin). (cs)
- MBDB ist das Kürzel der chemischen Substanz 2-Methylamino-1-(3,4-methylendioxyphenyl)butan. MBDB ist ein Homologon des MDMA (Ecstasy) und strukturell ein Amphetamin (1-Phenylpropan-2-amin). (de)
- La MBDB (2-méthylamino-1-(3,4-méthylènedioxyphényl)butane) est une substance psychotrope aux propriétés stimulantes et hallucinogènes de la famille des phényléthylamines. Il a été synthétisé par David Nichols. (fr)
- 1,3-Benzodioxolyl-N-methylbutanamine (N-methyl-1,3-benzodioxolylbutanamine, MBDB, 3,4-methylenedioxy-N-methyl-α-ethylphenylethylamine) is an entactogen of the phenethylamine chemical class. It is known by the street names Eden and Methyl-J. MBDB is a ring substituted amphetamine and an analogue of MDMA. Like MDMA, it has a methylene dioxy substitution at the 3 and 4 position on the aromatic ring; this is perhaps the most distinctive feature that structurally define analogues of MDMA, in addition to their unique effects, and as a class they are often referred to as "entactogens" to differentiate between typical psychostimulant amphetamines that (as a general rule) are not ring substituted. MBDB differs from MDMA by having an ethyl group instead of a methyl group attached to the alpha carbon; all other parts are identical. Modification at the alpha carbon is uncommon for substituted amphetamines. It has IC50 values of 784 nM against 5-HT, 7825 nM against dopamine, and 1233 nM against norepinephrine. Its metabolism has been described in scientific literature. MBDB was first synthesized by pharmacologist and medicinal chemist David E. Nichols and later tested by Alexander Shulgin and described in his book, PiHKAL: A Chemical Love Story. MBDB's dosage, according to PiHKAL, is 180–210 mg; the proper dosage relative to body mass seems unknown. Its duration is 4–6 hours, with noticeable after-effects lasting for 1–3 hours. MBDB was initially developed as a non-psychedelic entactogen. It has lower effects on the dopamine system in comparison to other entactogens such as MDMA. MBDB causes many mild, MDMA-like effects, in particular the lowering of social barriers and inhibitions, pronounced sense of empathy and compassion, mood lift, and mild euphoria, all of which are present. MBDB tends to produce less euphoria, psychedelia, and stimulation in comparison to MDMA. (en)
- L'MBDB (chiamato anche 1,3-benzodiossolil-N-metilbutanamina, N-metil-1,3-benzodiossolilbutanamina o 3,4-metilendiossi-N-metil-α-etilfeniletilammina) è una sostanza entactogena della classe chimica della fenetilammina. È conosciuto anche coi nomi gergali di Eden e Methyl-J. (it)
- MBDB — химическое соединение класса амфетаминов. Обладает эмпатогенным действием, сходным с действием MDMA. В отличие от MDMA не проявляет существенного психостимулирующего действия. Согласно PiHKAL, активная доза вещества находится в диапазоне 180—210 мг. (ru)
- N-Metylo-1,3-benzodioksolilobutanoamina (MBDB) – organiczny związek chemiczny, empatogenna substancja psychoaktywna, pochodna amfetaminy, analog MDMA. MBDB po raz pierwszy zostało otrzymane przez a dokładniej zbadane i opisane przez Alexandra Shulgina. Zgodnie z PIHKAL dawkowanie tej substancji waha się w przedziale 180–210 mg a czas działania wynosi 4 do 6 godzin. Efekty działania MBDB opisywane są jako podobne do MDMA, lecz mniej wyraźne i łagodniejsze. (pl)
|
| dbo:casNumber
| |
| dbo:fdaUniiCode
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 7867 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:c
| |
| dbp:caption
| |
| dbp:casNumber
| |
| dbp:chemspiderid
| |
| dbp:drugName
| |
| dbp:h
| |
| dbp:image
| |
| dbp:iupacName
| |
| dbp:legalAu
| |
| dbp:legalDe
| |
| dbp:legalUk
| |
| dbp:legalUs
|
- SCHEDULE 1 HALLUCINAGEN *POSITIONAL ISOMER OF MDEA (en)
|
| dbp:meltingPoint
| |
| dbp:n
| |
| dbp:o
| |
| dbp:pubchem
| |
| dbp:smiles
| |
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- USWVWJSAJAEEHQ-UHFFFAOYSA-N (en)
|
| dbp:synonyms
|
- Methylbenzodioxolylbutanamine; N-Methyl-1,3-benzodioxolylbutanamine; MBDB; 3,4-Methylenedioxy-N-methyl-butanphenamine; MDMB (en)
|
| dbp:unii
| |
| dbp:verifiedrevid
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- MBDB neboli N-metyl-1-(1,3-benzodioxol-5-yl)-2-butanamin je fenylethylamin chemický blízký MDMA (extázi). Je nazýván také "EDEN" nebo "Methyl-J". Používá se experimentálně v psychoterapii také jako droga. Poprvé byl syntetizován , později ho pro jeho psychoaktivní účinky zkoumal . Ten o něm napsal knihu PiHKAL (Phenyletylamines I Have Known And Loved - Fenyletylaminy které znám a miluji). V Evropě se vyskytuje ve formě tablet vydávaných za extázi, jedná se asi o 1 % případů. Někdy bývá s kombinaci s jinými látkami (MDMA, LSD, ketamin). (cs)
- MBDB ist das Kürzel der chemischen Substanz 2-Methylamino-1-(3,4-methylendioxyphenyl)butan. MBDB ist ein Homologon des MDMA (Ecstasy) und strukturell ein Amphetamin (1-Phenylpropan-2-amin). (de)
- La MBDB (2-méthylamino-1-(3,4-méthylènedioxyphényl)butane) est une substance psychotrope aux propriétés stimulantes et hallucinogènes de la famille des phényléthylamines. Il a été synthétisé par David Nichols. (fr)
- L'MBDB (chiamato anche 1,3-benzodiossolil-N-metilbutanamina, N-metil-1,3-benzodiossolilbutanamina o 3,4-metilendiossi-N-metil-α-etilfeniletilammina) è una sostanza entactogena della classe chimica della fenetilammina. È conosciuto anche coi nomi gergali di Eden e Methyl-J. (it)
- MBDB — химическое соединение класса амфетаминов. Обладает эмпатогенным действием, сходным с действием MDMA. В отличие от MDMA не проявляет существенного психостимулирующего действия. Согласно PiHKAL, активная доза вещества находится в диапазоне 180—210 мг. (ru)
- N-Metylo-1,3-benzodioksolilobutanoamina (MBDB) – organiczny związek chemiczny, empatogenna substancja psychoaktywna, pochodna amfetaminy, analog MDMA. MBDB po raz pierwszy zostało otrzymane przez a dokładniej zbadane i opisane przez Alexandra Shulgina. Zgodnie z PIHKAL dawkowanie tej substancji waha się w przedziale 180–210 mg a czas działania wynosi 4 do 6 godzin. Efekty działania MBDB opisywane są jako podobne do MDMA, lecz mniej wyraźne i łagodniejsze. (pl)
- 1,3-Benzodioxolyl-N-methylbutanamine (N-methyl-1,3-benzodioxolylbutanamine, MBDB, 3,4-methylenedioxy-N-methyl-α-ethylphenylethylamine) is an entactogen of the phenethylamine chemical class. It is known by the street names Eden and Methyl-J. MBDB is a ring substituted amphetamine and an analogue of MDMA. Like MDMA, it has a methylene dioxy substitution at the 3 and 4 position on the aromatic ring; this is perhaps the most distinctive feature that structurally define analogues of MDMA, in addition to their unique effects, and as a class they are often referred to as "entactogens" to differentiate between typical psychostimulant amphetamines that (as a general rule) are not ring substituted. MBDB differs from MDMA by having an ethyl group instead of a methyl group attached to the alpha carbon (en)
|
| rdfs:label
|
- MBDB (cs)
- MBDB (de)
- MBDB (it)
- MBDB (fr)
- MBDB (en)
- N-Metylo-1,3-benzodioksolilobutanoamina (pl)
- MBDB (ru)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- 1,3-Benzodioxolyl-N-methylbutanamine (en)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
